Providers WA

12/14/21: Health Advisory: COVID-19 Updates for Providers

COVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup recommend everyone 16 years or older get a COVID-19 vaccine booster dose at the recommended interval. This recommendation comes after Food and Drug Administration (FDA) expanded its emergency use authorization (EUA) for Pfizer-BioNTech 12/14/21: Health Advisory: COVID-19 Updates for Providers

11/23/21 Health Advisory: COVID-19 vaccine booster doses available to everyone 18 years or older

Health Advisory: COVID-19 Vaccine Booster Doses Available to Everyone 18 Years or Older Requested actions Be aware, following the Food and Drug Administration’s (FDA’s) decision to update its emergency use authorizations (EUAs) to allow COVID-19 vaccine booster doses for everyone 18 years or older, Centers for Disease Control and Prevention (CDC) and Western States Scientific 11/23/21 Health Advisory: COVID-19 vaccine booster doses available to everyone 18 years or older

9/27/2021 Health Advisory: COVID-19 Updates for Providers

doctor holding clipboard and writing

Requested actions Be aware, Washington State is currently experiencing a shortage of anti-SARS-CoV-2 monoclonal antibodies (MAbs). Adhere to National Institutes of Health (NIH) guidelines on the use and prioritization of MAbs. Be aware, on Sept. 24 the Western States Scientific Safety Review Workgroup and the Centers for Disease Control and Prevention (CDC) recommended a single booster dose of Pfizer-BioNTech (Comirnaty) 9/27/2021 Health Advisory: COVID-19 Updates for Providers

9/17/21 Health Advisory: COVID-19 Updates for Providers

doctor putting on a mask in white coat

Requested actions Do not administer or prescribe Ivermectin for prevention or treatment of COVID-19. The Centers for Disease Control and Prevention (CDC) issued a health alert about the rapid increase in Ivermectin prescriptions and report of severe illness associated with the use of Ivermectin to prevent or treat COVID-19. The evidence suggesting Ivermectin is safe or effective 9/17/21 Health Advisory: COVID-19 Updates for Providers

9/14/21 – Health Advisory: Be vigilant for measles and polio among newly arrived refugees from Afghanistan

blurry doctor and patient in background with stethoscope on a notebook

Requested actions Be vigilant for measles and polio in patients with compatible symptoms, especially among people who recently arrived from countries where measles and polio circulate, including Afghanistan. Be aware of immunization recommendations for people arriving from Afghanistan. Immediately report suspected cases of measles or polio. Background Afghanistan ranks seventh in the world for measles 9/14/21 – Health Advisory: Be vigilant for measles and polio among newly arrived refugees from Afghanistan

8/26/21 Health Advisory: COVID-19 Updates for Providers

doctor holding up stethoscope

Requested actions Be aware, the U.S. Food and Drug Administration (FDA) granted full authorization to Pfizer-BioNTech COVID-19 vaccine for people 16 years and older. Pfizer-BioNTech will now be referred to as Comirnaty (koe-mir’-na-tee). Pfizer-BioNTech COVID-19 vaccine continues to be available to people 12-15 years old and people who are moderately to severely immunocompromised through emergency use authorization (EUA). Be aware, monoclonal antibody treatment is 8/26/21 Health Advisory: COVID-19 Updates for Providers

8/16/21 – Health Advisory: COVID-19 Vaccine Update for Clinicians

blurry doctor office

Requested actions Be aware, the U.S. Food and Drug Administration (FDA) amended its emergency use authorizations (EUAs) for Pfizer and Moderna COVID-19 vaccines to allow an additional (third) dose for certain immunocompromised people. Be aware, the Advisory Committee on Immunization Practices (ACIP) authorized an additional (third) dose of Pfizer and Moderna COVID-19 vaccines under a revised EUA for certain people who 8/16/21 – Health Advisory: COVID-19 Vaccine Update for Clinicians

4/26/21 – Health Advisory: Johnson & Johnson COVID-19 Vaccine Update for Providers

hand holding handful of cloth face masks

Requested actions Be aware, Johnson & Johnson (J&J) COVID-19 vaccine is again authorized for use in people 18 years or older in Washington starting April 24. Discard any J&J Emergency Use Authorization (EUA) Fact Sheets you have on hand. Use the new J&J EUA Fact Sheet. Monitor and properly treat patients who develop signs and symptoms of thrombosis with thrombocytopenia syndrome (TTS)—severe headache, abdominal pain, leg pain or shortness of breath—within 3 weeks 4/26/21 – Health Advisory: Johnson & Johnson COVID-19 Vaccine Update for Providers

3/22/2021 – Health Advisory: COVID-19 Updates for Providers

doctor with stethoscope in white coat

Requested actions Be aware Washington State Department of Health (DOH) opened Phase 1B Tier 2 on March 17. DOH updated its Phase 1B guidance and released an expected timeline for moving into future tiers. Encourage people eligible in Phase 1A and Phase 1B Tiers 1 and 2 to get vaccinated. Direct patients to  vaccinelocator.doh.wa.gov to find vaccine providers near them, and to our COVID-19 3/22/2021 – Health Advisory: COVID-19 Updates for Providers

1/18/21 Health Advisory: COVID-19 Updates for Providers

dark haired woman with face mask

Requested actions Be aware, the state Department of Health (DOH) announced COVID-19 vaccine Phase 1B will start soon. People eligible in Phase 1A should get vaccinated now, before their priority ends. Be aware, DOH’s Phase Finder tool can tell users if they are eligible for Phase 1A and where they can get vaccinated. Starting Jan. 18, the tool will 1/18/21 Health Advisory: COVID-19 Updates for Providers